Smart Money Alert
Natco Pharma Limited
DecreasedSAST
NATCOPHARMPharmaceuticalsMarket Cap₹16K Cr
Value
₹11.63 Cr
Shares
1,15,000
Price
₹1,017.31
Stake
0.13% → 0.09%
SA
SANJAY NANNAPANENI and SATYA VANI NANNAPANENI
Promoter
The move
Sanjay Nannapaneni and Satya Vani Nannapaneni sold 1.15 lakh shares of Natco Pharma for ₹11.63 Cr at ₹1017.31 apiece, reducing the promoter group's stake from 0.13% to 0.09%.
About Natco Pharma Limited
Visit stock A vertically integrated pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Natco Pharma operates across three core business segments: finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services. The company maintains a strong research and development focus to drive innovation and develop specialized therapeutic solutions across oncology, cardiovascular, gastroenterology, and other critical therapeutic domains.
Get the next move the moment it happens.
Follow the investors and Natco Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Durga Devi Nannapaneni
Direction, size, price and stake change for this move, with what it means for the company.
24 Aug 2026. Sign in to see this move
LICNew position
LIC initiated a new position in Natco Pharma, acquiring 40,09,317 shares, representing a 2.24% stake. The investment is valued at ₹385.54 Cr based on Natco Pharma's share price of ₹961.60.
9 Jul 2026
Read more